Driven by our commitment to patients, we continue to push the boundaries of medicine and technology to develop new and better therapies where none existed before. We have a robust pipeline of product candidates in immuno-oncology and pain.
In addition to development in our established areas of focus, we are also expanding - through both in-house development and strategic acquisitions and partnerships - to other disease areas where there are unmet needs.Syntrix's dedication to scientific research and new drug development extends beyond the development of products.
In addition to development in our established areas of focus, we are also expanding - through both in-house development and strategic acquisitions and partnerships - to other disease areas where there are unmet needs.Syntrix's dedication to scientific research and new drug development extends beyond the development of products.
Services
Science at Syntrix is at the core of what we do, from the discovery of a promising therapeutic candidate to the preclinical and clinical research and development necessary to create a new medicine. We are "technology agnostic" at Syntrix. The starting point of all our research efforts is a significant medical need with the potential to develop a breakthrough therapy.
That spirit of teamwork defines our external partnerships, as we seek complementary strengths to help us bring products to the patients who need them most. At Syntrix, we realize that we don't have all the answers. In the complex, ever-evolving field of biopharmaceuticals, Syntrix relies on strong business relationships to help us succeed in our mission of making a major positive impact on patients worldwide.
Reviews
Be the first to review Syntrix Biosystems.
Write a Review
